Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound)
-1,500.00 In-Stock -4,000.00 In-Stock -1,200.00 In-Stock -400.00 In-Stock 15 other products in the same category: -1,300.00 In-Stock -4,000.00 In-Stock -1,200.00 In-Stock -2,999.00 In-Stock On sale
It is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps to lower blood sugar levels by increasing insulin secretion, decreasing glucagon secretion, and slowing gastric emptying
Orforglipron is anticipated to follow
Glutathione has anti-inflammatory properties that can help modulate the immune response and reduce excessive inflammation in the body
This slow titration is part of why Saxenda is well tolerated